| Package | hl7.at.fhir.gkl.ig-tooling |
| Type | CodeSystem |
| Id | Id |
| FHIR Version | R4 |
| Source | https://gabriel0316.github.io/ig-tooling-pages/ig/ig-tooling |
| Url | https://termgit.elga.gv.at/CodeSystem/eimpf-impfstoffe |
| Version | 2.34.0+20250122 |
| Status | active |
| Date | 2025-01-22 |
| Name | eimpf-impfstoffe |
| Title | eImpf_Impfstoffe |
| Experimental | False |
| Authority | hl7 |
| Description | Liste der Impfungen gelistet nach PZN. Hinweis: In der Liste der Impfstoffe sind idente Impfstoff Bezeichnungen mit unterschiedlichen PZN enthalten. Diese Präparate unterscheiden sich in der Packungsgröße oder der Zulassungsnummer. Die Attribute können unter den Details der einzelnen Konzepte nachgelesen werden. |
| Copyright | https://www.basg.gv.at/fuer-unternehmen/online-service/nutzungshinweise#termgit |
| Content | complete |
| ValueSet | |
https://termgit.elga.gv.at/ValueSet/eimpf-impfstoffe  | eImpf_Impfstoffe |
No resources found
FHIR{
"resourceType" : "CodeSystem",
"id" : "eimpf-impfstoffe",
"url" : "https://termgit.elga.gv.at/CodeSystem/eimpf-impfstoffe",
"identifier" : [
{
"use" : "official",
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:1.2.40.0.34.4.16.1"
}
],
"version" : "2.34.0+20250122",
"name" : "eimpf-impfstoffe",
"title" : "eImpf_Impfstoffe",
"status" : "active",
"date" : "2025-01-22",
"description" : "Liste der Impfungen gelistet nach PZN. Hinweis: In der Liste der Impfstoffe sind idente Impfstoff Bezeichnungen mit unterschiedlichen PZN enthalten. Diese Pr�parate unterscheiden sich in der Packungsgr��e oder der Zulassungsnummer. Die Attribute k�nnen unter den Details der einzelnen Konzepte nachgelesen werden.",
"copyright" : "https://www.basg.gv.at/fuer-unternehmen/online-service/nutzungshinweise#termgit",
"content" : "complete",
"count" : 210,
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"type" : "string"
},
{
"code" : "ZulassungsNummer",
"type" : "string"
},
{
"code" : "ELGA_Zulassungsstatus",
"type" : "string"
},
{
"code" : "ELGA_Inhaber",
"type" : "string"
},
{
"code" : "ELGA_G�ltigkeit",
"type" : "string"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"type" : "string"
},
{
"code" : "GroesseGewicht",
"type" : "string"
},
{
"code" : "ELGA_MedikationMengenart_code",
"type" : "string"
},
{
"code" : "ELGA_MedikationMengenart_text",
"type" : "string"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"type" : "string"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"type" : "string"
},
{
"code" : "ELGA_Packaging_01_code",
"type" : "string"
},
{
"code" : "ELGA_Packaging_01_text",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"type" : "string"
},
{
"code" : "ELGA_PartName",
"type" : "string"
},
{
"code" : "ELGA_whoATC_01_code",
"type" : "string"
},
{
"code" : "ELGA_whoATC_01_text",
"type" : "string"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"type" : "string"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"type" : "string"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"type" : "string"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"type" : "string"
},
{
"code" : "ELGA_Substanz_01_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_01_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_01",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"type" : "string"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"type" : "string"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"type" : "string"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"type" : "string"
},
{
"code" : "Domaene",
"type" : "string"
},
{
"code" : "ELGA_PackageReferenceNumber",
"type" : "string"
},
{
"code" : "ELGA_Packaging_02_code",
"type" : "string"
},
{
"code" : "ELGA_Packaging_02_text",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"type" : "string"
},
{
"code" : "ELGA_Substanz_02_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_02_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_02",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"type" : "string"
},
{
"code" : "ELGA_Substanz_03_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_03_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_03",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"type" : "string"
},
{
"code" : "ELGA_whoATC_02_code",
"type" : "string"
},
{
"code" : "ELGA_whoATC_02_text",
"type" : "string"
},
{
"code" : "ELGA_whoATC_03_code",
"type" : "string"
},
{
"code" : "ELGA_whoATC_03_text",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_04_code",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_04_text",
"type" : "string"
},
{
"code" : "ELGA_Substanz_04_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_04_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_04",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_05_code",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_05_text",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_06_code",
"type" : "string"
},
{
"code" : "ELGA_ImpfungIndikation_06_text",
"type" : "string"
},
{
"code" : "ELGA_Substanz_05_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_05_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_05_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_05_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_05_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_05",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_05",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_05_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_05_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_05",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_05",
"type" : "string"
},
{
"code" : "ELGA_Substanz_06_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_06_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_06_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_06_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_06_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_06",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_06",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_06_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_06_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_06",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_06",
"type" : "string"
},
{
"code" : "ELGA_Substanz_07_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_07_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_07_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_07_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_07_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_07",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_07",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_07_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_07_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_07",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_07",
"type" : "string"
},
{
"code" : "ELGA_Substanz_08_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_08_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_08_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_08_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_08_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_08",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_08",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_08_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_08_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_08",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_08",
"type" : "string"
},
{
"code" : "ELGA_Substanz_09_code",
"type" : "string"
},
{
"code" : "ELGA_Substanz_09_text",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_09_code",
"type" : "string"
},
{
"code" : "ELGA_ActiveIngredient_09_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_role_09_text",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_09",
"type" : "string"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_09",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_09_code",
"type" : "string"
},
{
"code" : "ELGA_ReferenceIngredient_09_text",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_09",
"type" : "string"
},
{
"code" : "ELGA_Reference_low_strength_unit_09",
"type" : "string"
},
{
"code" : "status",
"type" : "code"
},
{
"code" : "ELGA_MedikationDarreichungsform_02_code",
"type" : "string"
},
{
"code" : "ELGA_MedikationDarreichungsform_02_text",
"type" : "string"
}
],
"concept" : [
{
"code" : "0056489",
"display" : "TETANOL PUR FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Tetanol pur Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00079"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "GSK Vaccines GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Tetanol pur"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AM01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Tetanus-Toxoid"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:929064002"
}
]
},
{
"code" : "0514986",
"display" : "FSME-IMMUN FSPR 0,5ML NAD F",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "FSME-Immun 0,5 ml Erwachsene Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00174"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Corporation Austria Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "FSME-Immun"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:929592001"
}
]
},
{
"code" : "0515738",
"display" : "FSME-IMMUN FSPR 0,5ML NAD F",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "FSME-Immun 0,5 ml Erwachsene Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00174"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Corporation Austria Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "FSME-Immun"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:929592003"
}
]
},
{
"code" : "1076502",
"display" : "VAXIGRIP FSPR M.KANUELE",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "VAXIGRIP Injektionssupension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00215"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Vaccines"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VAXIGRIP"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:942778001"
}
]
},
{
"code" : "1079021",
"display" : "SANDOVAC FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Sandovac Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00235"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus S.r.l."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Sandovac"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:943596001"
}
]
},
{
"code" : "1258120",
"display" : "INFLUVAC FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Influvac - Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00216"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Viatris Austria GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Influvac"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:942663001"
}
]
},
{
"code" : "1260571",
"display" : "POLIO SALK MER FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Polio Salk \"Merieux\" - Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00068"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:1031000221108"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Poliomyelitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Polio Salk \"Merieux\""
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BF03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Poliomyelitis, trivalent, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709005"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "POLIOMYELITISVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:929410001"
}
]
},
{
"code" : "1265597",
"display" : "INFLUVAC FSPR 0,5ML O.KANUEL",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Influvac - Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00216"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Viatris Austria GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Influvac"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:942663003"
}
]
},
{
"code" : "1276939",
"display" : "ACT-HIB TRSTAMP +LSM",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Act-HIB Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00101"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Vaccines"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836380007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Haemophilus influenzae Typ B Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Act-HIB"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AG01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Haemophilus-influenzae B, gereinigtes Antigen konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1712678"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004292"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004292"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:931020001"
}
]
},
{
"code" : "1290520",
"display" : "DT-REDUCT MER FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "dT-reduct \u001EM�rieux\u001C - Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00144"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836502000"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Tetanus Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "dT-reduct \u001EM�rieux\u001C"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AM51"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Tetanus-Toxoid, Kombinationen mit Diphtherie-Toxoid"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "2"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:935726001"
}
]
},
{
"code" : "1292200",
"display" : "ENGERIX-B FSPR 10MCG/0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "ENGERIX-B 10 Mikrogramm/0,5 ml Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00145"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "ENGERIX-B"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis B, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:933950001"
}
]
},
{
"code" : "1301057",
"display" : "HAVRIX FSPR 1440 ERW",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Havrix (Hepatitis A-Impfstoff) 1440 El.U/ml - Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00173"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836375003"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis A Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Havrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis A, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708213"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-A-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:934339001"
}
]
},
{
"code" : "1304498",
"display" : "TWINRIX ERW INJ FSPR 1ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Twinrix Erwachsene Suspension zur Injektion in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/96/020"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836493003"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Hepatitis A-Hepatitis B Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836375003"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Hepatitis A Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Twinrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC20"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Kombinationen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708213"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-A-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:941714001"
}
]
},
{
"code" : "1309515",
"display" : "TWINRIX KIND INF FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Twinrix Kinder Suspension zur Injektion in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/97/029"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836493003"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Hepatitis A-Hepatitis B Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836375003"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Hepatitis A Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Twinrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC20"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Kombinationen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708213"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-A-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "5"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945852001"
}
]
},
{
"code" : "1315496",
"display" : "HAVRIX FSPR 720 JUNIOR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Havrix (Hepatitis A-Impfstoff) Junior 720 El.U/0,5 ml - Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00201"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836375003"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis A Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Havrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis A, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708213"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-A-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:940331001"
}
]
},
{
"code" : "1316018",
"display" : "VARILRIX PLV+LSM INJSUSP",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Varilrix Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00180"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836495005"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Varizellen Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Varilrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BK01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Varicella, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1710861"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "VARIZELLA VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "3.3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "log10 PFU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "3.3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "log10 PFU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000116178"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Powder and solvent for suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:935093001"
}
]
},
{
"code" : "1325750",
"display" : "PRIORIX PLV+LSM IMPFDS",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Priorix Pulver in einer Durchstechflasche und L�sungsmittel in einer Fertigspritze zur Herstellung einer Injektionsl�sung"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00224"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836494009"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Masern-Mumps-R�teln Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871738001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Mumps Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836382004"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Masern Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:836388000"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "R�teln Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Priorix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BD52"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Masern, Kombinationen mit Mumps und R�teln, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708247"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "MASERNVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089348"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "MEASLES VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "log10 CCID50"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089348"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "MEASLES VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "log10 CCID50"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1709047"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "R�TELNVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091879"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "RUBELLA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "log10 CCID50"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091879"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "RUBELLA VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "3"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "log10 CCID50"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1708220"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "MUMPSVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089281"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "MUMPS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "3.7"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "log10 CCID50"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089281"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "MUMPS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "3.7"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "log10 CCID50"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073868"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:943257002"
}
]
},
{
"code" : "1329251",
"display" : "VIVOTIF KPS",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Vivotif - Kapseln"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00011"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "PaxVax Ltd."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "3"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073496"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Blisterpackung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836390004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Typhus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Vivotif"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AP01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Typhus, oral, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073619"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "zum Einnehmen"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1712651"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "SALMONELLA SPEC."
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004228"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "SALMONELLA SPEC."
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004228"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "SALMONELLA SPEC."
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073375"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Hartkapsel"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:927311001"
}
]
},
{
"code" : "1333991",
"display" : "TYPHERIX IJLSG 25MCG/0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Typherix 25 Mikrogramm/0,5 ml Injektionsl�sung"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00237"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836390004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Typhus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Typherix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AP03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Typhus, gereinigtes Polysaccharid-Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1710721"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "SALMONELLA SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000000955"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "SALMONELLA SPEC. (Extracts, Products)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0.025"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000000955"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "SALMONELLA SPEC. (Extracts, Products)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0.025"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073863"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsl�sung"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:943879001"
}
]
},
{
"code" : "1349762",
"display" : "FLUAD FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "FLUAD Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00250"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus S.r.l."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "FLUAD"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:944561001"
}
]
},
{
"code" : "1350268",
"display" : "HBVAXPRO IJSUS FLA 40MCG",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "HBVAXPRO 40 Mikrogramm/ml Injektionssuspension, Hepatitis B-Impfstoff (rDNS)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/01/183"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073497"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Flasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "HBVAXPRO"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis B, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945563001"
}
]
},
{
"code" : "1364721",
"display" : "ENGERIX-B FSPR 20MCG/1ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "ENGERIX-B 20 Mikrogramm/1 ml Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00008"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "ENGERIX-B"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis B, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:927485001"
}
]
},
{
"code" : "2228368",
"display" : "TD PUR ERW FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Td-pur f�r Erwachsene und Heranwachsende"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00234"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Astro-Pharma Vertrieb Und Handel Von Pharmazeutischen Produkten GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "HBVAXPRO"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis B, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "2.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "2.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945559001"
}
]
},
{
"code" : "2467788",
"display" : "REPEVAX FSPR 0,5ML+1 KANUELE",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Repevax Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00284"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836508001"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Pertussis-Poliomyelitis-Tetanus Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:1031000221108"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Poliomyelitis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:601000221108"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Pertussis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_04_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_04_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Repevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07CA02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Diphtherie-Pertussis-Poliomyelitis-Tetanus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708214"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "15.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "15.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "2"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1709005"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "POLIOMYELITISVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "80"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "DAgU"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "80"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "DAgU"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_04",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:946126003"
}
]
},
{
"code" : "2467794",
"display" : "TETRAVAC FSPR +2KANUELE",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "TETRAVAC Injektionssuspension"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00226"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Vaccines"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836508001"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Pertussis-Poliomyelitis-Tetanus Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:1031000221108"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Poliomyelitis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:601000221108"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Pertussis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_04_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_04_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "TETRAVAC"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07CA02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Diphtherie-Pertussis-Poliomyelitis-Tetanus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708214"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1709005"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "POLIOMYELITISVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"valueString" : "40"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_04",
"valueString" : "40"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:943439003"
}
]
},
{
"code" : "2469988",
"display" : "REVAXIS FSPR 0,5ML+1 KANUELE",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "REVAXIS - Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00248"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836505003"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Poliomyelitis-Tetanus Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:1031000221108"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Poliomyelitis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "REVAXIS"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07CA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Diphtherie-Poliomyelitis-Tetanus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "2"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1709005"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "POLIOMYELITISVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:944303001"
}
]
},
{
"code" : "2469994",
"display" : "TYPHIM VI FSPR 0,5ML +1 KAN.",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Typhim Vi Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00093"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836390004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Typhus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Typhim Vi"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AP03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Typhus, gereinigtes Polysaccharid-Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1710721"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "SALMONELLA SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000000955"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "SALMONELLA SPEC. (Extracts, Products)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0.025"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000000955"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "SALMONELLA SPEC. (Extracts, Products)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0.025"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074047"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:929005003"
}
]
},
{
"code" : "2470017",
"display" : "STAMARIL PLV+LSM DFL+FSPR+2K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "STAMARIL Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension Gelbfieber - Lebendimpfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00298"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073497"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Flasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836385002"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Gelbfieber Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "STAMARIL"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BL01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Gelbfieber, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708212"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "GELBFIEBERVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089243"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "YELLOW FEVER VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089243"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "YELLOW FEVER VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:934434003"
}
]
},
{
"code" : "2472795",
"display" : "PROQUAD PLV+LSM FSPR +2K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "ProQuad (Masern-Mumps-R�teln-Varizellen-Lebendimpfstoff) Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/05/323"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:838280004"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Masern-Mumps-R�teln-Varizellen Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871738001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Mumps Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836495005"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Varizellen Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:836382004"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Masern Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_04_code",
"valueString" : "2.16.840.1.113883.6.96:836388000"
},
{
"code" : "ELGA_ImpfungIndikation_04_text",
"valueString" : "R�teln Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "ProQuad"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BD54"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Masern, Kombinationen mit Mumps, R�teln und Varicella, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708247"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "MASERNVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089348"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "MEASLES VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089348"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "MEASLES VIRUS"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1709047"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "R�TELNVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091879"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "RUBELLA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091879"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "RUBELLA VIRUS"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1710861"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "VARIZELLA VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:1708220"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "MUMPSVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000089281"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "MUMPS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000089281"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "MUMPS VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:948521001"
}
]
},
{
"code" : "2472803",
"display" : "ROTATEQ QUETSCHTB 2ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "RotaTeq (Rotavirus-Lebendimpfstoff) L�sung zum Einnehmen"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/06/348"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073561"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Tube"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836387005"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Rotavirus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "RotaTeq"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BH02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Rotavirus, pentavalent, lebend, Reassortanten"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073619"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "zum Einnehmen"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1707958"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088029"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088029"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073646"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "L�sung zum Einnehmen"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:949079001"
}
]
},
{
"code" : "2472826",
"display" : "ZOSTAVAX PLV +LSM IJSUS FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "ZOSTAVAX (Zoster-Lebendimpfstoff) Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/06/341"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073497"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Flasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871919004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Herpes Zoster Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "ZOSTAVAX"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BK02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Zoster Virus lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1710861"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "VARIZELLA VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "19400"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "PFU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "19400"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "PFU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:950051001"
}
]
},
{
"code" : "2479314",
"display" : "INFANRIX HEXA PLV INJS FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Infanrix hexa Pulver und Suspension zur Herstellung einer Injektionssuspension"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/00/152"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:871896006"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836380007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Haemophilus influenzae Typ B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:1031000221108"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Poliomyelitis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_04_code",
"valueString" : "2.16.840.1.113883.6.96:601000221108"
},
{
"code" : "ELGA_ImpfungIndikation_04_text",
"valueString" : "Pertussis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_05_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_05_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_06_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_06_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Infanrix hexa"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07CA09"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1712678"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004292"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004292"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708214"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "58"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "58"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_04",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_05_code",
"valueString" : "1.2.40.0.34.5.156:1709005"
},
{
"code" : "ELGA_Substanz_05_text",
"valueString" : "POLIOMYELITISVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ActiveIngredient_05_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Ingredient_role_05_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_05",
"valueString" : "80"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_05",
"valueString" : "DAgU"
},
{
"code" : "ELGA_ReferenceIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ReferenceIngredient_05_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Reference_low_strength_05",
"valueString" : "80"
},
{
"code" : "ELGA_Reference_low_strength_unit_05",
"valueString" : "DAgU"
},
{
"code" : "ELGA_Substanz_06_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_06_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_06_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_06_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_06",
"valueString" : "40"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_06",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_06_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_06",
"valueString" : "40"
},
{
"code" : "ELGA_Reference_low_strength_unit_06",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945199001"
}
]
},
{
"code" : "3511764",
"display" : "MMRVAXPRO PLV+LSM FSPR +2K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "M-M-RVAXPRO Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension in einer Fertigspritze, Masern-Mumps-R�teln-Lebendimpfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/06/337"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073497"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Flasche"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836494009"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Masern-Mumps-R�teln Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871738001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Mumps Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836382004"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Masern Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:836388000"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "R�teln Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "M-M-RVAXPRO"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BD52"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Masern, Kombinationen mit Mumps und R�teln, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708247"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "MASERNVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089348"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "MEASLES VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1000"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "TCID50"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089348"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "MEASLES VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1000"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "TCID50"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1709047"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "R�TELNVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091879"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "RUBELLA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "1000"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "TCID50"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091879"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "RUBELLA VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "1000"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "TCID50"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1708220"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "MUMPSVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089281"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "MUMPS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "12500"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "TCID50"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089281"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "MUMPS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "12500"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "TCID50"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:950050001"
}
]
},
{
"code" : "3513450",
"display" : "CERVARIX FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Cervarix (Humaner Papillomvirus-Impstoff [Typen 16, 18] (rekombinant, adjuvantiert, adsorbiert) 20 �g/20 �g Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/07/419"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836379009"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Humane Papillomaviren Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Cervarix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BM02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Humaner Papillomvirus-Impfstoff (Typen 16,18)"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1707612"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 16 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000086312"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000086312"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1707613"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 18 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000086313"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000086313"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:953981001"
}
]
},
{
"code" : "3514171",
"display" : "GARDASIL SPR +2KAN",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Gardasil Injektionssuspension; Humaner Papillomvirus-Impfstoff [Typen 6, 11, 16, 18] (rekombinant, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/06/357"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073497"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Flasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836379009"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Humane Papillomaviren Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Gardasil"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BM01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Humaner Papillomvirus-Impfstoff (Typen 6,11,16,18)"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1707610"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 11 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000086292"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "40"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000086292"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "40"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1707611"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 6 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000086311"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000086311"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1707612"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 16 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000086312"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "40"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000086312"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "40"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:1707613"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 18 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000086313"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000086313"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_04",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:949687001"
}
]
},
{
"code" : "3519599",
"display" : "HBVAXPRO IJSUS FSP 10MCG 2KN",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "HBVAXPRO 10 Mikrogramm/ml Injektionssuspension in einer Fertigspritze, Hepatitis B-Impfstoff (rDNS)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/01/183"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "HBVAXPRO"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis B, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945561001"
}
]
},
{
"code" : "3521662",
"display" : "MENJUGATE PLV +LSM FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Menjugate 10 Mikrogramm Pulver und L�sungsmittel zur Herstellung einer Injektionssupension"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00335"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Vaccines S.r.l."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871866001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Meningokokken Serotyp C Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Menjugate"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AH"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Meningokokken-Impfstoffe"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1705481"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "NEISSERIA MENINGITIDIS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "12.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "12.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:948250001"
}
]
},
{
"code" : "3528434",
"display" : "FLUVACCINOL INJ-SUS FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluvaccinol Subunit Impfstoff - Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00310"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Viatris Austria GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluvaccinol Subunit Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:948601001"
}
]
},
{
"code" : "3532424",
"display" : "NEISVAC-C FSPR 2 NADEL 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "NeisVac-C Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00261"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Corporation Austria Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871866001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Meningokokken Serotyp C Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "NeisVac-C"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AH"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Meningokokken-Impfstoffe"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1705481"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "NEISSERIA MENINGITIDIS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945231001"
}
]
},
{
"code" : "3533837",
"display" : "SYNFLORIX FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Synflorix Injektionssuspension in einer Fertigspritze Pneumokokkenpolysaccharid-Konjugatimpfstoff (adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/09/508"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836398006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Pneumokokken Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Synflorix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AL02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709526"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:952809001"
}
]
},
{
"code" : "3537551",
"display" : "IXIARO FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "IXIARO Injektionssuspension Japanische-Enzephalitis-Virus Impfstoff (inaktiviert, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/08/501"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Valneva Austria GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836378001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Japanische Enzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "IXIARO"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Encephalitis, japanische, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708380"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "JAPANISCHE ENZEPHALITIS VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089823"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "JAPANESE ENCEPHALITIS VIRUS (INACTIVATED)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "6"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089823"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "JAPANESE ENCEPHALITIS VIRUS (INACTIVATED)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "6"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:952832001"
}
]
},
{
"code" : "3539969",
"display" : "INTANZA 15MCG FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "INTANZA (Influenza-Spaltimpfstoff (inaktiviert)) 15 Mikrogramm/Stamm Injektionssuspension"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/08/505"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Vaccines"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "INTANZA"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073595"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intradermale Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:953327001"
}
]
},
{
"code" : "3756589",
"display" : "PREVENAR 13 FSPR 0,5ML+ND",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Prevenar 13 Injektionssuspension Pneumokokkenpolysaccharid-Konjugatimpfstoff (13valent, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/09/590"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Europe Ma EEIG"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836398006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Pneumokokken Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Prevenar"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AL02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709526"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "15.4"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "15.4"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:954203001"
}
]
},
{
"code" : "3760993",
"display" : "ROTARIX SUS FAPPLIK.1,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Rotarix Suspension zum Einnehmen in einem Fertigapplikator f�r die orale Verabreichung"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/05/330"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073491"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Applikator"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836387005"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Rotavirus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Rotarix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BH01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Rotavirus, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073619"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "zum Einnehmen"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1707958"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088029"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1500000"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "CCID50"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088029"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1500000"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "CCID50"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073362"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension zum Einnehmen"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:952028001"
}
]
},
{
"code" : "3761739",
"display" : "INTANZA 9MCG FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "INTANZA (Influenza-Spaltimpfstoff (inaktiviert)) 9 Mikrogramm/Stamm Injektionssuspension"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/08/505"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Pasteur MSD S.N.C."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "INTANZA"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073595"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intradermale Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:954534001"
}
]
},
{
"code" : "3762986",
"display" : "PRIORIX TETRA PLV DFL FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Priorix - Tetra Pulver in einer Durchstechflasche und L�sungsmittel in einer Fertigspritze zur Herstellung einer Injektionsl�sung"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00333"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:838280004"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Masern-Mumps-R�teln-Varizellen Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871738001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Mumps Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836495005"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Varizellen Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:836382004"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Masern Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_04_code",
"valueString" : "2.16.840.1.113883.6.96:836388000"
},
{
"code" : "ELGA_ImpfungIndikation_04_text",
"valueString" : "R�teln Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Priorix - Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BD54"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Masern, Kombinationen mit Mumps, R�teln und Varicella, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708247"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "MASERNVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089348"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "MEASLES VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089348"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "MEASLES VIRUS"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1709047"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "R�TELNVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091879"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "RUBELLA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000091879"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "RUBELLA VIRUS"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1710861"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "VARIZELLA VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:1708220"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "MUMPSVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000089281"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "MUMPS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000089281"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "MUMPS VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073868"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:950727001"
}
]
},
{
"code" : "3782291",
"display" : "MENVEO PLV+LSM DFL",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Menveo Pulver und L�sung zur Herstellung einer Injektionsl�sung Meningokokken-Gruppen A-, C-, W135- und Y-Konjugat-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/10/614"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Vaccines S.r.l."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871873006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Meningokokken Serotyp A+C+W135+Y Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Menveo"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AH08"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Meningokokkus tetravalent, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1705481"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "NEISSERIA MENINGITIDIS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "25"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "25"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "32.7"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "32.7"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000116173"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Powder and solution for solution for injection"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:954002001"
}
]
},
{
"code" : "3904699",
"display" : "VAQTA FSPR INJ.SUS",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "VAQTA 50 E/1 ml Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00192"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836375003"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis A Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VAQTA"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis A, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708213"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-A-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "50"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "U"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "50"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "U"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:941305003"
}
]
},
{
"code" : "3904713",
"display" : "VAQTA K FSPR INJ.SUS",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "VAQTA K pro infantibus 25 E/0,5 ml Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00193"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836375003"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis A Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VAQTA K pro infantibus"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Hepatitis A, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708213"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-A-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "25"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "U"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "25"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "U"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:941306003"
}
]
},
{
"code" : "3909165",
"display" : "NIMENRIX PLV+LSM FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Nimenrix - Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung in einer Fertigspritze Meningokokken-Gruppen A, C, W-135 und Y-Konjugatimpfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/12/767"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Europe Ma EEIG"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871873006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Meningokokken Serotyp A+C+W135+Y Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Nimenrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AH08"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Meningokokkus tetravalent, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1705481"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "NEISSERIA MENINGITIDIS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "132"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "132"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073868"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:7616395001"
}
]
},
{
"code" : "3911995",
"display" : "OPTAFLU INJ-SUS FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Optaflu (Oberfl�chenantigen, inaktiviert, in Zellkultur hergestellt) Injektionssuspension in einer Fertigspritze, Influenza Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/07/394"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Novartis Vaccines and Diagnostics GmbH & Co. KG"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Optaflu"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709054"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:950234002"
}
]
},
{
"code" : "3919867",
"display" : "OPTAFLU INJ-SUS FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Optaflu (Oberfl�chenantigen, inaktiviert, in Zellkultur hergestellt) Injektionssuspension in einer Fertigspritze, Influenza Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/07/394"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Novartis Vaccines and Diagnostics GmbH & Co. KG"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Optaflu"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709054"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:950234001"
}
]
},
{
"code" : "3920095",
"display" : "BEXSERO INJ.SUS FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Bexsero Injektionssuspension in Fertigspritze Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/12/812"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Vaccines S.r.l."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:1981000221108"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Meningokokken Serotyp B Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Bexsero"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AH09"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Meningokokken B, Multikomponenten-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1705481"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "NEISSERIA MENINGITIDIS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "87.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "87.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:7523681001"
}
]
},
{
"code" : "3925649",
"display" : "FSME-IMMUN FSPR 0,25ML NAD B",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "FSME-Immun 0,25 ml Junior Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00269"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Corporation Austria Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "FSME-Immun"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0.25"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0.25"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945533002"
}
]
},
{
"code" : "3925655",
"display" : "FSME-IMMUN FSPR 0,25ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "FSME-Immun 0,25 ml Junior Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00269"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Corporation Austria Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "FSME-Immun"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0.25"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0.25"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945533003"
}
]
},
{
"code" : "3927186",
"display" : "FLUARIX INJ.SUS FSPR O.NADEL",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluarix Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00382"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluarix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:956721002"
}
]
},
{
"code" : "3928168",
"display" : "HEXYON IJSUS FSPR +2 KAN",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Hexyon Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/13/829"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:871896006"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836380007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Haemophilus influenzae Typ B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:1031000221108"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Poliomyelitis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_04_code",
"valueString" : "2.16.840.1.113883.6.96:601000221108"
},
{
"code" : "ELGA_ImpfungIndikation_04_text",
"valueString" : "Pertussis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_05_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_05_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_06_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_06_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Hexyon"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07CA09"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1712678"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004292"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "12"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004292"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "12"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708214"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "50"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "50"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_04",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_05_code",
"valueString" : "1.2.40.0.34.5.156:1709005"
},
{
"code" : "ELGA_Substanz_05_text",
"valueString" : "POLIOMYELITISVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ActiveIngredient_05_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Ingredient_role_05_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_05",
"valueString" : "80"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_05",
"valueString" : "DAgU"
},
{
"code" : "ELGA_ReferenceIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ReferenceIngredient_05_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Reference_low_strength_05",
"valueString" : "80"
},
{
"code" : "ELGA_Reference_low_strength_unit_05",
"valueString" : "DAgU"
},
{
"code" : "ELGA_Substanz_06_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_06_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_06_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_06_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_06",
"valueString" : "40"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_06",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_06_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_06",
"valueString" : "40"
},
{
"code" : "ELGA_Reference_low_strength_unit_06",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:958677001"
}
]
},
{
"code" : "3932448",
"display" : "FSME-IMMUN FSPR 0,5ML NAD B",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "FSME-Immun 0,5 ml Erwachsene Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00174"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Corporation Austria Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "FSME-Immun"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:929592002"
}
]
},
{
"code" : "3932454",
"display" : "FSME-IMMUN FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "FSME-Immun 0,5 ml Erwachsene Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00174"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Corporation Austria Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "FSME-Immun"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:929592004"
}
]
},
{
"code" : "4202025",
"display" : "FLUENZ TETRA NA-SPRAY",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluenz Tetra Nasenspray, Suspension Influenza-Impfstoff (lebend-attenuiert, nasal)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/13/887"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "AstraZeneca AB"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073553"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Spraydose"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluenz Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073615"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "nasale Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709054"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073809"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Nasenspray, Suspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:7614259001"
}
]
},
{
"code" : "4202031",
"display" : "FLUENZ TETRA NA-SPRAY",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluenz Tetra Nasenspray, Suspension Influenza-Impfstoff (lebend-attenuiert, nasal)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/13/887"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "AstraZeneca AB"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073553"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Spraydose"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluenz Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073615"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "nasale Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709054"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073809"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Nasenspray, Suspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:7614259002"
}
]
},
{
"code" : "4202462",
"display" : "PNEUMOVAX 23 DFL 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "PNEUMOVAX 23 Injektionsl�sung in einer Durchstechflasche"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00263"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840. {
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "12.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "12.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:7344274001"
}
]
},
{
"code" : "4465799",
"display" : "RABIPUR GSK PLV+LSM INJ FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Rabipur Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:237614"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836393002"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Tollwut Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Rabipur"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BG01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Tollwut, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708399"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RABIESVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089883"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RABIESVIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089883"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RABIESVIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000075585"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Powder and solvent for solution for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:"
}
]
},
{
"code" : "4466942",
"display" : "TRUMENBA IJSUS FSPR+NAD0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Trumenba Injektionssuspension in einer Fertigspritze, Meningokokken-Gruppe B-Impfstoff (rekombinant, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/17/1187"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Europe Ma EEIG"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:1981000221108"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Meningokokken Serotyp B Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Trumenba"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AH09"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Meningokokken B, Multikomponenten-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1705481"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "NEISSERIA MENINGITIDIS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "120"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g/ml"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "120"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g/ml"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:9181536001"
}
]
},
{
"code" : "4467841",
"display" : "VAXIGRIP TETRA FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "VaxigripTetra Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:137203"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VaxigripTetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:8205809001"
}
]
},
{
"code" : "4467858",
"display" : "VAXIGRIP TETRA FSPR O.K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "VaxigripTetra Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:137203"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VaxigripTetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:8205809002"
}
]
},
{
"code" : "4475131",
"display" : "GARDASIL 9 FSPR +2KAN",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Gardasil 9 Injektionssuspension in einer Fertigspritze; 9-valenter Humaner Papillomvirus-Impfstoff (rekombinant, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/15/1007"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - Paralleldistribution"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Abacus Medicine A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073497"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Flasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836379009"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Humane Papillomaviren Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Gardasil 9"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BM03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Humaner Papillomvirus-Impfstoff (Typen 6, 11, 16, 18, 31, 33, 45, 52, 58)"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1707610"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 11 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000086292"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000086292"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:8280099"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 52 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:900000004924"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:900000004924"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1707611"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 6 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000086311"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000086311"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:8280082"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 31 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:900000004921"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:900000004921"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_04",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_05_code",
"valueString" : "1.2.40.0.34.5.156:8280097"
},
{
"code" : "ELGA_Substanz_05_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 45 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:900000004923"
},
{
"code" : "ELGA_ActiveIngredient_05_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_05_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_05",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_05",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:900000004923"
},
{
"code" : "ELGA_ReferenceIngredient_05_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_05",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_05",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_06_code",
"valueString" : "1.2.40.0.34.5.156:8280113"
},
{
"code" : "ELGA_Substanz_06_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 58 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:900000004925"
},
{
"code" : "ELGA_ActiveIngredient_06_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_06_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_06",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_06",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:900000004925"
},
{
"code" : "ELGA_ReferenceIngredient_06_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_06",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_06",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_07_code",
"valueString" : "1.2.40.0.34.5.156:1707612"
},
{
"code" : "ELGA_Substanz_07_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 16 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_07_code",
"valueString" : "1.2.40.0.34.5.221:100000086312"
},
{
"code" : "ELGA_ActiveIngredient_07_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_07_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_07",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_07",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_07_code",
"valueString" : "1.2.40.0.34.5.221:100000086312"
},
{
"code" : "ELGA_ReferenceIngredient_07_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_07",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_07",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_08_code",
"valueString" : "1.2.40.0.34.5.156:1707613"
},
{
"code" : "ELGA_Substanz_08_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 18 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_08_code",
"valueString" : "1.2.40.0.34.5.221:100000086313"
},
{
"code" : "ELGA_ActiveIngredient_08_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_08_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_08",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_08",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_08_code",
"valueString" : "1.2.40.0.34.5.221:100000086313"
},
{
"code" : "ELGA_ReferenceIngredient_08_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_08",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_08",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_09_code",
"valueString" : "1.2.40.0.34.5.156:8280087"
},
{
"code" : "ELGA_Substanz_09_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 33 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_09_code",
"valueString" : "1.2.40.0.34.5.221:900000004922"
},
{
"code" : "ELGA_ActiveIngredient_09_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_09_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_09",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_09",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_09_code",
"valueString" : "1.2.40.0.34.5.221:900000004922"
},
{
"code" : "ELGA_ReferenceIngredient_09_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_09",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_09",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:14055394001"
}
]
},
{
"code" : "4477035",
"display" : "PREVENAR INJ.SUS13 0,5ML+NAD",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Prevenar 13 Injektionssuspension Pneumokokkenpolysaccharid-Konjugatimpfstoff (13valent, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/09/590"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - Paralleldistribution"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Orifarm GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836398006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Pneumokokken Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Prevenar"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AL02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709526"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "15.4"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "15.4"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:12551543001"
}
]
},
{
"code" : "4482993",
"display" : "INFLUVAC TETRA FSPR0,5ML M.K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Influvac Tetra Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:238034"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Viatris Healthcare Limited"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Influvac Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:9260511001"
}
]
},
{
"code" : "4961340",
"display" : "VIVOTIF MSR HKPS",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Vivotif 2 x 10^9 - 2 x 10^10 CFU magensaftresistente Hartkapsel"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:238557"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "3"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073496"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Blisterpackung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836390004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Typhus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Vivotif"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AP01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Typhus, oral, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073619"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "zum Einnehmen"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1712651"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "SALMONELLA SPEC."
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004228"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "SALMONELLA SPEC."
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "2000"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "million CFU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004228"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "SALMONELLA SPEC."
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "2000"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "million CFU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073376"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "magensaftresistente Hartkapsel"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:9893149001"
}
]
},
{
"code" : "4963675",
"display" : "FLUCELVAX TETRA FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Flucelvax Tetra - Injektionssuspension in einer Fertigspritze; Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, in Zellkultur hergestellt)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/18/1326"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Flucelvax Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:10454424003"
}
]
},
{
"code" : "4963681",
"display" : "FLUCELVAX TETRA IJSUS FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Flucelvax Tetra - Injektionssuspension in einer Fertigspritze; Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, in Zellkultur hergestellt)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/18/1326"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Flucelvax Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:"
},
{
"code" : "status",
"valueCode" : "retired"
}
]
},
{
"code" : "4966403",
"display" : "FLUCELVAX TETRA FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Flucelvax Tetra - Injektionssuspension in einer Fertigspritze; Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, in Zellkultur hergestellt)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/18/1326"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Flucelvax Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:10454424001"
}
]
},
{
"code" : "4973521",
"display" : "ROTARIX SUS TUBE 1,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Rotarix Suspension zum Einnehmen"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/05/330"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073561"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Tube"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836387005"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Rotavirus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Rotarix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BH01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Rotavirus, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073619"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "zum Einnehmen"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1707958"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088029"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1500000"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "CCID50"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088029"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ROTAVIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1500000"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "CCID50"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073362"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension zum Einnehmen"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:953659002"
}
]
},
{
"code" : "4977134",
"display" : "ENCEPUR FSPR 0,25ML KIND +ND",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Encepur 0,25 ml f�r Kinder Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00268"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Encepur"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:"
}
]
},
{
"code" : "4977140",
"display" : "ENCEPUR FSPR 0,5ML +ND",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Encepur 0,5 ml Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00236"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Encepur"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:"
}
]
},
{
"code" : "4977714",
"display" : "ENCEPUR FSPR 0,5ML BN",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Encepur 0,5 ml Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00236"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Encepur"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:930486001"
}
]
},
{
"code" : "4977720",
"display" : "ENCEPUR FSPR 0,25ML KIND BN",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Encepur 0,25 ml f�r Kinder Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00268"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836403007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Fr�hsommer-Meningoenzephalitis Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Encepur"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BA01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "FSME, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FR�HSOMMER-MENINGOENCEPHALITIS-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0.75"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089915"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TICK-BORNE ENCEPHALITIS VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0.75"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:945710002"
}
]
},
{
"code" : "4977737",
"display" : "RABIPUR BN PLV+LSM INJ FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Rabipur Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:237614"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836393002"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Tollwut Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Rabipur"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BG01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Tollwut, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708399"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RABIESVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089883"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RABIES VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "2.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089883"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RABIES VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "2.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000075585"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Powder and solvent for solution for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:8139400001"
}
]
},
{
"code" : "4983502",
"display" : "SHINGRIX PLV+SUSP IJSUS DFL",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Shingrix Pulver und Suspension zur Herstellung einer Injektionssuspension, Herpes-Zoster-Impfstoff (rekombinant, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/18/1272"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - Paralleldistribution"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Abacus Medicine A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871919004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Herpes Zoster Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Shingrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BK03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Zoster, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:10792954"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "VARICELLA ZOSTERVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005105"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "VARICELLA ZOSTERVIRUS (EXTRACT, PRODUCT)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "50"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005105"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "VARICELLA ZOSTERVIRUS (EXTRACT, PRODUCT)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "50"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073867"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationDarreichungsform_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000174019"
},
{
"code" : "ELGA_MedikationDarreichungsform_02_text",
"valueString" : "Suspension zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13657008001"
}
]
},
{
"code" : "4985398",
"display" : "SHINGRIX PLV+SUSP IJSUS DFL",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Shingrix Pulver und Suspension zur Herstellung einer Injektionssuspension, Herpes-Zoster-Impfstoff (rekombinant, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/18/1272"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:871919004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Herpes Zoster Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Shingrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BK03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Zoster, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:10792954"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "VARICELLA ZOSTERVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005105"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "VARICELLA ZOSTERVIRUS (EXTRACT, PRODUCT)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "50"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005105"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "VARICELLA ZOSTERVIRUS (EXTRACT, PRODUCT)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "50"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074032"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Powder and suspension for suspension for injection"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:9663290001"
}
]
},
{
"code" : "4985702",
"display" : "FLUAD FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "FLUAD Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00250"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus S.r.l."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "FLUAD"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:944561003"
}
]
},
{
"code" : "4988787",
"display" : "VARIVAX PLV+LSM FSPR +2KAN",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "VARIVAX Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00300"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme Ges.m.b.H."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836495005"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Varizellen Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VARIVAX"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BK01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Varicella, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1710861"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "VARIZELLA VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1350"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "PFU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000001096"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "VARICELLA VIRUS OKA STRAIN (LIVE, ATTENUATED)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1350"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "PFU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:947028002"
}
]
},
{
"code" : "4989539",
"display" : "COMIRNATY COV19 KONZ30 195x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty 30 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "195"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13516687002"
}
]
},
{
"code" : "4989918",
"display" : "EFLUELDA TETRA FSP 0,7ML O.K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Efluelda Tetra Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:240088"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Efluelda Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "240"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "240"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074047"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:11972298006"
}
]
},
{
"code" : "4989947",
"display" : "TD PUR ERW FSPR 0,5ML O.ND",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Td-pur f�r Erwachsene und Heranwachsende"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00234"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Astro-Pharma Vertrieb Und Handel Von Pharmazeutischen Produkten GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836502000"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Tetanus Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Td-pur"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AM51"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Tetanus-Toxoid, Kombinationen mit Diphtherie-Toxoid"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "2"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000001796"
}
]
},
{
"code" : "4990123",
"display" : "FLUAD TETRA FSPR+ND 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluad Tetra, Injektionssuspension in einer Fertigspritze, Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1433"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluad Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:11826029003"
}
]
},
{
"code" : "4990146",
"display" : "FLUAD TETRA FSPR+ND 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluad Tetra, Injektionssuspension in einer Fertigspritze, Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1433"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluad Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:11826029001"
}
]
},
{
"code" : "4990459",
"display" : "VAXZEVRIA COV19 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Vaxzevria Injektionssuspension; COVID-19-Impfstoff (ChAdOx1-S [rekombinant])"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1529"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "AstraZeneca AB"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Vaxzevria"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13509460003"
}
]
},
{
"code" : "4991720",
"display" : "JCOVDEN COV19 10x5",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "JCOVDEN Injektionssuspension; COVID-19-Impfstoff (Ad26.COV2-S [rekombinant])"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1525"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. Janssen Cilag International S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "JCOVDEN Injektionssuspension"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "22.3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "log10 U"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "22.3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "log10 U"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13695913002"
}
]
},
{
"code" : "5424472",
"display" : "PFIZER-BION COV19 KONZ30 1x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty 30 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13516687003"
}
]
},
{
"code" : "5426867",
"display" : "MODERNA/SPIKEVAX COV19 1x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Spikevax, Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1507"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Moderna Biotech Spain S.L."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Spikevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:100945371"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0.2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0.2"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13662341002"
}
]
},
{
"code" : "5426873",
"display" : "MODERNA/SPIKEVAX COV19 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Spikevax, Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1507"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Moderna Biotech Spain S.L."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Spikevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:100945371"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "2"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13662341003"
}
]
},
{
"code" : "5502433",
"display" : "GARDASIL 9 FSPR +2KAN",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Gardasil 9 Injektionssuspension in einer Fertigspritze; 9-valenter Humaner Papillomvirus-Impfstoff (rekombinant, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/15/1007"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - Paralleldistribution"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Orifarm GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073497"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Flasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836379009"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Humane Papillomaviren Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Gardasil 9"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BM03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Humaner Papillomvirus-Impfstoff (Typen 6, 11, 16, 18, 31, 33, 45, 52, 58)"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1707610"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 11 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000086292"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000086292"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:8280099"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 52 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:900000004924"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:900000004924"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1707611"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 6 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000086311"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000086311"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:8280082"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 31 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:900000004921"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:900000004921"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_04",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_05_code",
"valueString" : "1.2.40.0.34.5.156:8280113"
},
{
"code" : "ELGA_Substanz_05_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 58 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:900000004925"
},
{
"code" : "ELGA_ActiveIngredient_05_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_05_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_05",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_05",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:900000004925"
},
{
"code" : "ELGA_ReferenceIngredient_05_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_05",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_05",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_06_code",
"valueString" : "1.2.40.0.34.5.156:1707612"
},
{
"code" : "ELGA_Substanz_06_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 16 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:100000086312"
},
{
"code" : "ELGA_ActiveIngredient_06_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_06_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_06",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_06",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:100000086312"
},
{
"code" : "ELGA_ReferenceIngredient_06_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_06",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_06",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_07_code",
"valueString" : "1.2.40.0.34.5.156:8280097"
},
{
"code" : "ELGA_Substanz_07_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 45 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_07_code",
"valueString" : "1.2.40.0.34.5.221:900000004923"
},
{
"code" : "ELGA_ActiveIngredient_07_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_07_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_07",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_07",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_07_code",
"valueString" : "1.2.40.0.34.5.221:900000004923"
},
{
"code" : "ELGA_ReferenceIngredient_07_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_07",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_07",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_08_code",
"valueString" : "1.2.40.0.34.5.156:1707613"
},
{
"code" : "ELGA_Substanz_08_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 18 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_08_code",
"valueString" : "1.2.40.0.34.5.221:100000086313"
},
{
"code" : "ELGA_ActiveIngredient_08_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_08_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_08",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_08",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_08_code",
"valueString" : "1.2.40.0.34.5.221:100000086313"
},
{
"code" : "ELGA_ReferenceIngredient_08_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_08",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_08",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_09_code",
"valueString" : "1.2.40.0.34.5.156:8280087"
},
{
"code" : "ELGA_Substanz_09_text",
"valueString" : "HUMANES PAPILLOMVIRUS-TYP 33 L1-PROTEIN"
},
{
"code" : "ELGA_ActiveIngredient_09_code",
"valueString" : "1.2.40.0.34.5.221:900000004922"
},
{
"code" : "ELGA_ActiveIngredient_09_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_09_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_09",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_09",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_09_code",
"valueString" : "1.2.40.0.34.5.221:900000004922"
},
{
"code" : "ELGA_ReferenceIngredient_09_text",
"valueString" : "HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_09",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_09",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100086383001"
}
]
},
{
"code" : "5502522",
"display" : "JCOVDEN COV19 20x5",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "JCOVDEN Injektionssuspension; COVID-19-Impfstoff (Ad26.COV2-S [rekombinant])"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1525"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. Janssen Cilag International S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "20"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "JCOVDEN Injektionssuspension"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "22.3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "log10 U"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "22.3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "log10 U"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13695913003"
}
]
},
{
"code" : "5505414",
"display" : "VAXNEUVANCE IJSUS FSPR",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Vaxneuvance Injektionssuspension in einer Fertigspritze; Pneumokokken-Polysaccharid-Konjugatimpfstoff(15-valent, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1591"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Merck Sharp & Dohme B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836398006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Pneumokokken Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Vaxneuvance"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AL02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709526"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "32"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "32"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "2"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000000629"
}
]
},
{
"code" : "5506342",
"display" : "COMIRNATY COV19 INJ30 195x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty 30 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "195"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000000195"
}
]
},
{
"code" : "5506359",
"display" : "COMIRNATY COV19 INJ30 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty 30 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000000196"
}
]
},
{
"code" : "5506431",
"display" : "VALNEVA COV19 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff (inaktiviert, adjuvantiert) Valneva Injektionssuspension; COVID-19-Impfstoff (inaktiviert, adjuvantiert, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1624"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Valneva Austria GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "COVID-19-Impfstoff (inaktiviert, adjuvantiert) Valneva Injektionssuspension"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1710147"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000000378"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORONAVIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "165"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "AU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000000378"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORONAVIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "165"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "AU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002120"
}
]
},
{
"code" : "5506448",
"display" : "COMIRNATY COV19 KONZ10 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty 10 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000000483"
}
]
},
{
"code" : "5506945",
"display" : "VAXELIS IJSUS FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Vaxelis Injektionssuspension in einer Fertigspritze Diphtherie-Tetanus-Pertussis(azellul�r, aus Komponenten)-Hepatitis-B(rDNA)-Poliomyelitis(inaktiviert)-Haemophilus-Typ-b(konjugiert)-Adsorbat-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/15/1079"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "MCM Vaccine B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:871896006"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836380007"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Haemophilus influenzae Typ B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:1031000221108"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Poliomyelitis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_04_code",
"valueString" : "2.16.840.1.113883.6.96:601000221108"
},
{
"code" : "ELGA_ImpfungIndikation_04_text",
"valueString" : "Pertussis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_05_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_05_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_06_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_06_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Vaxelis"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07CA09"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1712678"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004292"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004292"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HAEMOPHILUS SPEC. (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1705481"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "NEISSERIA MENINGITIDIS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "25"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000076483"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "NEISSERIA MENINGITIDIS"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "25"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1708214"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "24"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "24"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_04_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_04_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_04",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_04_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_04_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_04",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_04",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_05_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_05_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_05_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_05_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_05",
"valueString" : "5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_05",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_05_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_05_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_05",
"valueString" : "5"
},
{
"code" : "ELGA_Reference_low_strength_unit_05",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_06_code",
"valueString" : "1.2.40.0.34.5.156:1709005"
},
{
"code" : "ELGA_Substanz_06_text",
"valueString" : "POLIOMYELITISVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ActiveIngredient_06_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Ingredient_role_06_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_06",
"valueString" : "40"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_06",
"valueString" : "DAgU"
},
{
"code" : "ELGA_ReferenceIngredient_06_code",
"valueString" : "1.2.40.0.34.5.221:100000091781"
},
{
"code" : "ELGA_ReferenceIngredient_06_text",
"valueString" : "POLIOMYELITIS VACCINE"
},
{
"code" : "ELGA_Reference_low_strength_06",
"valueString" : "40"
},
{
"code" : "ELGA_Reference_low_strength_unit_06",
"valueString" : "DAgU"
},
{
"code" : "ELGA_Substanz_07_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_07_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_07_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_07_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_07_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_07",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_07",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_07_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_07_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_07",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_07",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:7898984006"
}
]
},
{
"code" : "5508341",
"display" : "APEXXNAR IJSUS FSPR 0,5ML+ND",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Prevenar 20 Injektionssuspension in einer Fertigspritze; Pneumokokkenpolysaccharid-Konjugatimpfstoff (20-valent, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1612"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Europe Ma EEIG"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836398006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Pneumokokken Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Prevenar 20"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AL02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709526"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:"
}
]
},
{
"code" : "5509702",
"display" : "FLUAD TETRA FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluad Tetra, Injektionssuspension in einer Fertigspritze, Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1433"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluad Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:11826029002"
}
]
},
{
"code" : "5511774",
"display" : "PREVENAR 13 FSPR 0,5ML+N",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Prevenar 13 Injektionssuspension Pneumokokkenpolysaccharid-Konjugatimpfstoff (13valent, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/09/590"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - Paralleldistribution"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Abacus Medicine A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836398006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Pneumokokken Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Prevenar"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AL02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709526"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "15.4"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "15.4"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000001886"
}
]
},
{
"code" : "5516820",
"display" : "COMIRNATY COV19 BA1 195x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Original/Omicron BA.1 (15/15 Mikrogramm)/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "195"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101271284"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RILTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000042045"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RILTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000042045"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RILTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002457"
}
]
},
{
"code" : "5516837",
"display" : "COMIRNATY COV19 BA1 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Original/Omicron BA.1 (15/15 Mikrogramm)/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101271284"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RILTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000042045"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RILTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000042045"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RILTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002456"
}
]
},
{
"code" : "5516843",
"display" : "COMIRNATY COV19 BA4/5 195x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Original/Omicron BA.4-5 (15/15 Mikrogramm)/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "195"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101271286"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000046473"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000046473"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002462"
}
]
},
{
"code" : "5516866",
"display" : "COMIRNATY COV19 BA4/5 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Original/Omicron BA.4-5 (15/15 Mikrogramm)/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101271286"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000046473"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000046473"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "15"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "15"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002461"
}
]
},
{
"code" : "5516984",
"display" : "COMIRNATY KO3 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty 3 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002939"
}
]
},
{
"code" : "5516990",
"display" : "COMIRNATY KO1,5/1,5 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Original/Omicron BA.4-5 (1,5/1,5 Mikrogramm)/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Biontech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101271286"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005639"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "1.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005639"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "1.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "1.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "1.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "5517015",
"display" : "COMIRNATY KO5/5 BA4/5 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Original/Omicron BA.4-5 (5/5 Mikrogramm)/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101271286"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000046473"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000046473"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "FAMTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101102201"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000019018"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "TOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "5"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000003368"
}
]
},
{
"code" : "5517245",
"display" : "SPIKEVAX COV19 BA1 10x5",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Spikevax bivalent Original/Omicron BA.1 (50 Mikrogramm / 50 Mikrogramm)/ml Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1507"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Moderna Biotech Spain S.L."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Spikevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:100945371"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "500"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "500"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101271282"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000043661"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "500"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000043661"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "500"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002458"
}
]
},
{
"code" : "5517825",
"display" : "SPIKEVAX COV19 BA1 10x1",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Spikevax bivalent Original/Omicron BA.1 25 Mikrogramm/25 Mikrogramm Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1507"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Moderna Biotech Spain S.L."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Spikevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:100945371"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "250"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "250"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101271282"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000043661"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "250"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000043661"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "250"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002943"
}
]
},
{
"code" : "5517831",
"display" : "SPIKEVAX COV19 BA1 FSPR 10x1",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Spikevax bivalent Original/Omicron BA.1 25 Mikrogramm/25 Mikrogramm Injektionsdispersion in Fertigspritze; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1507"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Moderna Biotech Spain S.L."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Spikevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:100945371"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "250"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "250"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101271282"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000043661"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "250"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000043661"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "IMELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "250"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000027808"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion in einer Fertigspritze"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000002941"
}
]
},
{
"code" : "5517908",
"display" : "VIDPREVTYN COV19 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "VidPrevtyn Beta L�sung und Emulsion zur Herstellung einer Emulsion zur Injektion; COVID-19-Impfstoff (rekombinant, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1580"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - aufgehoben"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Pasteur"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "false"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VidPrevtyn Beta"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000025182"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Solution and emulsion for emulsion for injection"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000003175"
}
]
},
{
"code" : "5518670",
"display" : "QDENGA PLV+LSM IJLSG FSPR+ND",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Qdenga Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung in einer Fertigspritze; Dengue-Fieber tetravalenter Impfstoff (lebend, attenuiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/22/1699"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Takeda GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840563003"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Dengue-Fieber Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Qdenga"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX04"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Dengue-Impfstoffe"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:8982661"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "DENGUE-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004988"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "DENGUE VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "14.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "log10 PFU/dose"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004988"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "DENGUE VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "14.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "log10 PFU/dose"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073868"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000004040"
}
]
},
{
"code" : "5518730",
"display" : "SPIKEVAX COV19 BA4/5 10x5",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Spikevax bivalent Original/Omicron BA.4-5 (50 Mikrogramm/50 Mikrogramm)/ml Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1507"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Moderna Biotech Spain S.L."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Spikevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:100945371"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "500"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "500"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101424909"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "DAVESOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000046472"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "DAVESOMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "500"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000046472"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "DAVESOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "500"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000003385"
}
]
},
{
"code" : "5519103",
"display" : "BEYFORTUS FSP 50MG/0,5ML O.K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Beyfortus 50 mg Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/22/1689"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:108723008"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Respiratorisches Synzytial-Virus (RSV)"
},
{
"code" : "ELGA_PartName",
"valueString" : "Beyfortus"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J06BD08"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Nirsevimab"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:102325627"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "NIRSEVIMAB"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000177600"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "NIRSEVIMAB"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "50"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000177600"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NIRSEVIMAB"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "50"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074047"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000008363"
}
]
},
{
"code" : "5519126",
"display" : "BEYFORTUS FSP 100MG/1ML O.K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Beyfortus 100 mg Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/22/1689"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:108723008"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Respiratorisches Synzytial-Virus (RSV)"
},
{
"code" : "ELGA_PartName",
"valueString" : "Beyfortus"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J06BD08"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Nirsevimab"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:102325627"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "NIRSEVIMAB"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000177600"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "NIRSEVIMAB"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "100"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000177600"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "NIRSEVIMAB"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "100"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074047"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000000807"
}
]
},
{
"code" : "5520075",
"display" : "PREVENAR 20 FSPR 0,5ML+ND",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Prevenar 20 Injektionssuspension in einer Fertigspritze; Pneumokokkenpolysaccharid-Konjugatimpfstoff (20-valent, adsorbiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1612"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Europe Ma EEIG"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836398006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Pneumokokken Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Prevenar 20"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AL02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709526"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "46.2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000092730"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "STREPTOCOCCUS PNEUMONIAE"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "46.2"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "51"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "51"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:13924983002"
}
]
},
{
"code" : "5520483",
"display" : "SPIKEVAX COV19 BA4/5 10x1",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Spikevax bivalent Original/Omicron BA.4-5 25 Mikrogramm/25 Mikrogramm/ml Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1507"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Moderna Biotech Spain S.L."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Spikevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:100945371"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "250"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000015561"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ELASOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "250"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101424909"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "DAVESOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000046472"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "DAVESOMERAN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "250"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000046472"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "DAVESOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "250"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000003748"
}
]
},
{
"code" : "5523808",
"display" : "VERORAB PLV+LSM IJSUS 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Verorab Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension Tollwut-Impfstoff, inaktiviert"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:241712"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836393002"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Tollwut Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VERORAB"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BG01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Tollwut, inaktiviert, ganzes Virus"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073595"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intradermale Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708399"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RABIESVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089883"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RABIES VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "3.25"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089883"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RABIES VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "3.25"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073869"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000007157"
}
]
},
{
"code" : "5525380",
"display" : "AREXVY PLV+SUSP IJSUS DFL",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Arexvy Pulver und Suspension zur Herstellung einer Injektionssuspension, Respiratorischer Synzytial-Virus (RSV)-Impfstoff (rekombinant, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/23/1740"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "N.V. GlaxoSmithKline Biologicals S.A."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:108723008"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Respiratorisches Synzytial-Virus (RSV)"
},
{
"code" : "ELGA_PartName",
"valueString" : "Arexvy"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Impfstoffe"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101377744"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RESPIRATORISCHES SYNCYTIALVIRUS, REKOMBINANT (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005640"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RESPIRATORY SYNCYTIAL VIRUS, RECOMBINANT (EXTRACT, PRODUCT)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "120"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005640"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RESPIRATORY SYNCYTIAL VIRUS, RECOMBINANT (EXTRACT, PRODUCT)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "120"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074032"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Powder and suspension for suspension for injection"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000015416"
}
]
},
{
"code" : "5525687",
"display" : "ABRYSVO IJLSG PLV+LSM DFL",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Abrysvo Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung, Respiratorischer Synzytial-Virus (RSV)-Impfstoff (bivalent, rekombinant)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/23/1752"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Pfizer Europe Ma EEIG"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_Packaging_02_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_02_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:108723008"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Respiratorisches Synzytial-Virus (RSV)"
},
{
"code" : "ELGA_PartName",
"valueString" : "Abrysvo"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX05"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Respiratorischer Synzytial-Virus (RSV)-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:101633062"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RESPIRATORISCHES SYNZYTIALVIRUS, SUBTYP A, STABILISIERTES PR�FUSION-F-PROTEIN 847A"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000013700"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROTEIN 847A"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0.06"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000013700"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROTEIN 847A"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0.06"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:101633065"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "RESPIRATORISCHES SYNZYTIALVIRUS, SUBTYP B, STABILISIERTES PR�FUSION-F-PROTEIN 847B"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000013701"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP B, STABILIZED PREFUSION F PROTEIN 847B"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "0.06"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:300000013701"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP B, STABILIZED PREFUSION F PROTEIN 847B"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "0.06"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "mg"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073868"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000016081"
}
]
},
{
"code" : "5526391",
"display" : "SPIKEVAX XBB.1.5 INJ50 1x1",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Spikevax XBB.1.5 50 Mikrogramm Injektionsdispersion; COVID-19-mRNA-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1507"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Moderna Biotech Spain S.L."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073550"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Einzeldosisbeh�ltnis"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Spikevax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:102567408"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "ANDUSOMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000051178"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "ANDUSOMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "0.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000051178"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "ANDUSOMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "0.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "mg"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000017865"
}
]
},
{
"code" : "5526847",
"display" : "NUVAXOVID XBB.1.5 INJ 2x5",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Nuvaxovid XBB.1.5 Injektionsdispersion; COVID-19-Impfstoff (rekombinant, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1618"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Novavax CZ a.s."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "2"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Nuvaxovid"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN04"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19, Proteinuntereinheit"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000017627"
}
]
},
{
"code" : "5527775",
"display" : "COMIRNATY XBB.1.5 INJ30 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Omicron XBB.1.5 30 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:102301406"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000051270"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000051270"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000015869"
}
]
},
{
"code" : "5528243",
"display" : "COMIRNATY XBB.1.5 INJ10 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Omicron XBB.1.5 10 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:102301406"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000051270"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000051270"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000022784"
}
]
},
{
"code" : "5528289",
"display" : "COMIRNATY XBB.1.5 KO3 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty Omicron XBB.1.5 3 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:102301406"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000051270"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000051270"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "RAXTOZINAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000022785"
}
]
},
{
"code" : "5534108",
"display" : "TWINRIX ERW INJ FSPR 1ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Twinrix Erwachsene Suspension zur Injektion in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/96/020"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - Paralleldistribution"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "SynCo pharma B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836493003"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Hepatitis A-Hepatitis B Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836374004"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Hepatitis B Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:836375003"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Hepatitis A Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Twinrix"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BC20"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Kombinationen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708213"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "HEPATITIS-A-VIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089244"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "HEPATITIS A VIRUS"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708175"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "HEPATITIS-B-VIRUS-ANTIGEN"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000089111"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "HEPATITIS B SURFACE ANTIGEN"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000029707"
}
]
},
{
"code" : "5534284",
"display" : "IXCHIQ INJ PLV+LSM FSP 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "IXCHIQ Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung Chikungunya-Impfstoff (lebend)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/24/1828"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Valneva Austria GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:1345042009"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Chikungunya Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "IXCHIQ"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "andere virale Impfstoffe"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:103756768"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CHIKUNGUNYA VIRUS, STAMM DELTA5NSP3, LEBEND ATTENUIERT"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000056146"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CHIKUNGUNYA VIRUS, STRAIN DELTA5NSP3, LIVE ATTENUATED"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "log10 TCID50"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000056146"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CHIKUNGUNYA VIRUS, STRAIN DELTA5NSP3, LIVE ATTENUATED"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "log10 TCID50"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073868"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Pulver und L�sungsmittel zur Herstellung einer Injektionsl�sung"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000017267"
}
]
},
{
"code" : "5534491",
"display" : "INFLUVAC TETRA FSPR0,5ML O.K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Influvac Tetra Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:238034"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Viatris Healthcare Limited"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Influvac Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000025881"
}
]
},
{
"code" : "5536969",
"display" : "FLUENZ NA-SPRAY",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluenz Nasenspray, Suspension; Influenza-Impfstoff (lebend-attenuiert, nasal)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/24/1816"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "AstraZeneca AB"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073550"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Einzeldosisbeh�ltnis"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluenz"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073615"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "nasale Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709054"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "19.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "log10 FFU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "19.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "log10 FFU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073809"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Nasenspray, Suspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000023839"
}
]
},
{
"code" : "5536975",
"display" : "FLUENZ NA-SPRAY",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluenz Nasenspray, Suspension; Influenza-Impfstoff (lebend-attenuiert, nasal)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/24/1816"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "AstraZeneca AB"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073550"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Einzeldosisbeh�ltnis"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluenz"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073615"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "nasale Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709054"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "19.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "log10 FFU"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "19.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "log10 FFU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073809"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Nasenspray, Suspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000023838"
}
]
},
{
"code" : "5540089",
"display" : "NUVAXOVID JN.1 INJ 10x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Nuvaxovid JN.1 Injektionsdispersion; COVID-19-Impfstoff (rekombinant, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1618"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Novavax CZ a.s."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Nuvaxovid"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN04"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19, Proteinuntereinheit"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "2.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "2.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000030729"
}
]
},
{
"code" : "5541887",
"display" : "COMIRNATY JN.1 INJ30 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty JN.1 30 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:103327076"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005679"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005679"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000027426"
}
]
},
{
"code" : "5541924",
"display" : "COMIRNATY JN.1 INJ10 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty JN.1 10 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:103327076"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005679"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005679"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000027571"
}
]
},
{
"code" : "5541947",
"display" : "COMIRNATY JN.1 KO3 10x3",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty JN.1 3 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:103327076"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005679"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005679"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "BRETOVAMERAN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000027573"
}
]
},
{
"code" : "5543308",
"display" : "DTAP BOOSTER FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "dTaP Booster Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:2-00405"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "AJ Vaccines A/S"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "5"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_K_code",
"valueString" : "2.16.840.1.113883.6.96:836503005"
},
{
"code" : "ELGA_ImpfungIndikation_K_text",
"valueString" : "Diphtherie-Pertussis-Tetanus Impfstoffkombination"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836381006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Diphtherie Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_02_code",
"valueString" : "2.16.840.1.113883.6.96:601000221108"
},
{
"code" : "ELGA_ImpfungIndikation_02_text",
"valueString" : "Pertussis Impfstoff"
},
{
"code" : "ELGA_ImpfungIndikation_03_code",
"valueString" : "2.16.840.1.113883.6.96:1101000221104"
},
{
"code" : "ELGA_ImpfungIndikation_03_text",
"valueString" : "Tetanus Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "dTaP Booster"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07AJ52"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Pertussis, gereinigtes Antigen, Kombinationen mit Toxoiden"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708214"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000089248"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "BORDETELLA PERTUSSIS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_Substanz_02_code",
"valueString" : "1.2.40.0.34.5.156:1708114"
},
{
"code" : "ELGA_Substanz_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ActiveIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Ingredient_role_02_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_02",
"valueString" : "2"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_02_code",
"valueString" : "1.2.40.0.34.5.221:100000088868"
},
{
"code" : "ELGA_ReferenceIngredient_02_text",
"valueString" : "CORYNEBACTERIUM DIPHTHERIAE"
},
{
"code" : "ELGA_Reference_low_strength_02",
"valueString" : "2"
},
{
"code" : "ELGA_Reference_low_strength_unit_02",
"valueString" : "IU"
},
{
"code" : "ELGA_Substanz_03_code",
"valueString" : "1.2.40.0.34.5.156:1708219"
},
{
"code" : "ELGA_Substanz_03_text",
"valueString" : "CLOSTRIDIUM TETANI (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ActiveIngredient_03_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Ingredient_role_03_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_03",
"valueString" : "20"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_03",
"valueString" : "IU"
},
{
"code" : "ELGA_ReferenceIngredient_03_code",
"valueString" : "1.2.40.0.34.5.221:100000089278"
},
{
"code" : "ELGA_ReferenceIngredient_03_text",
"valueString" : "CLOSTRIDIUM TETANI"
},
{
"code" : "ELGA_Reference_low_strength_03",
"valueString" : "20"
},
{
"code" : "ELGA_Reference_low_strength_unit_03",
"valueString" : "IU"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:958879004"
}
]
},
{
"code" : "5611903",
"display" : "NUVAXOVID COV19 1x10",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Nuvaxovid Injektionsdispersion; COVID-19-Impfstoff (rekombinant, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/21/1618"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Novavax CZ a.s."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073497"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Flasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Nuvaxovid"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "25"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000005514"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "CORONAVIRUS (EXTRACT, PRODUCTS)"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "25"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000000605"
}
]
},
{
"code" : "5801354",
"display" : "IAA FLUENZ TETRA NA-SPRAY",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluenz Tetra Nasenspray, Suspension Influenza-Impfstoff (lebend-attenuiert, nasal)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/13/887"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "AstraZeneca AB"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073553"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Spraydose"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluenz Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, lebend abgeschw�cht"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073615"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "nasale Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709054"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073809"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Nasenspray, Suspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "5801437",
"display" : "IAA FLUAD TETRA FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluad Tetra, Injektionssuspension in einer Fertigspritze, Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1433"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluad Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "5801472",
"display" : "IAA VAXIGRIP TETRA FSPR O.K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "VaxigripTetra Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:137203"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Pasteur Europe"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "VaxigripTetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "5801495",
"display" : "IAA FLUARIX TETRA FSPR +2ND",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluarix Tetra Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:235552"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Glaxosmithkline Pharma GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluarix Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1709054"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091897"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "INFLUENZA VIRUS"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "60"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "5939880",
"display" : "ZBI ZOONOT IFLU SQR FSP0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Zoonotic Influenza Vaccine Seqirus Injektionssuspension in einer Fertigspritze Zoonotischer Influenzaimpfstoff (H5N8) (Oberfl�chenantigen, inaktiviert, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/23/1761"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus S.r.l."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:30041000234101"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza H5 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Zoonotic Influenza Vaccine Seqirus"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "7.5"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "7.5"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000023459"
}
]
},
{
"code" : "6050111",
"display" : "VAXIGRIP TRIVL FSP 0,5MLO.K.",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Vaxigrip Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:242481"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Vaxigrip"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000024000"
}
]
},
{
"code" : "6050128",
"display" : "EFLUELDA TRIVA FSP 0,5ML O.K",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Efluelda Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:242437"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Winthrop Industrie"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Efluelda"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "180"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "180"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000022068"
}
]
},
{
"code" : "6051317",
"display" : "COMIRNATY KP.2 INJ30 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty KP.2 30 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073530"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Mehrdosenbeh�ltnis"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:103593295"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "KP.2 KODIERENDE MRNA, EIN COVID-19-MRNA-IMPFSTOFF"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000056787"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "5'-CAPPED MRNA ENCODING SARS-COV-2, OMICRON VARIANT KP.2, SPIKE PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000056787"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "5'-CAPPED MRNA ENCODING SARS-COV-2, OMICRON VARIANT KP.2, SPIKE PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "30"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000030318"
}
]
},
{
"code" : "6051323",
"display" : "COMIRNATY KP.2 INJ10 10x6",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty KP.2 10 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073550"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Einzeldosisbeh�ltnis"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:103593295"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "KP.2 KODIERENDE MRNA, EIN COVID-19-MRNA-IMPFSTOFF"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000056787"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "5'-CAPPED MRNA ENCODING SARS-COV-2, OMICRON VARIANT KP.2, SPIKE PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000056787"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "5'-CAPPED MRNA ENCODING SARS-COV-2, OMICRON VARIANT KP.2, SPIKE PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "10"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074068"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000030321"
}
]
},
{
"code" : "6051346",
"display" : "COMIRNATY KP.2 KO3 10x3",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Comirnaty KP.2 3 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/20/1528"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "BioNTech Manufacturing GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073530"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Mehrdosenbeh�ltnis"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Comirnaty"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BN01"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "COVID-19-mRNA-Impfstoff"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:103593295"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "KP.2 KODIERENDE MRNA, EIN COVID-19-MRNA-IMPFSTOFF"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000056787"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "5'-CAPPED MRNA ENCODING SARS-COV-2, OMICRON VARIANT KP.2, SPIKE PROTEIN"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:300000056787"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "5'-CAPPED MRNA ENCODING SARS-COV-2, OMICRON VARIANT KP.2, SPIKE PROTEIN"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "3"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000015705"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Konzentrat zur Herstellung einer Injektionsdispersion"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000030322"
}
]
},
{
"code" : "6052771",
"display" : "INFLUVAC TRI FSPR 0,5ML O.K.",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Influvac Tri Injektionssuspension in einer Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:242282"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Viatris Austria GmbH"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Influvac Tri"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_02_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000021405"
}
]
},
{
"code" : "6054586",
"display" : "FLUAD IJSUS FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluad Injektionssuspension in einer Fertigspritze; Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, adjuvantiert)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/24/1878"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Fluad"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000026363"
}
]
},
{
"code" : "6054592",
"display" : "FLUCELVAX IJSUS FSPR 0,5ML",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Flucelvax Injektionssuspension in einer Fertigspritze; Influenza-Impfstoff (Oberfl�chenantigen, inaktiviert, in Zellkultur hergestellt)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/24/1879"
},
{
"code" : "ELGA_Zulassungsstatus",
"valueString" : "GA - zugelassen"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Seqirus Netherlands B.V."
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Flucelvax"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_Ingredient_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Ingredient_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Reference_low_strength_01",
"valueString" : "45"
},
{
"code" : "ELGA_Reference_low_strength_unit_01",
"valueString" : "�g HA"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "ELGA_PackageReferenceNumber",
"valueString" : "1.2.40.0.34.4.26:100000026360"
}
]
},
{
"code" : "AUSL_000001",
"display" : "COVID-19-Impfstoff CVnCoV (CureVac)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff CVnCoV (CureVac)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:CVnCoV"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "CVnCoV"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000002",
"display" : "COVID-19-Impfstoff NVX-CoV2373 (Novavax)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff NVX-CoV2373 (Novavax)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:NVX-CoV2373"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "NVX-CoV2373"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "status",
"valueCode" : "retired"
}
]
},
{
"code" : "AUSL_000003",
"display" : "COVID-19-Impfstoff Sputnik-V (Gamaleya)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Sputnik-V (Gamaleya)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Sputnik-V"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Sputnik-V"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000004",
"display" : "COVID-19-Impfstoff Convidecia (CanSino Biologics)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Convidecia (CanSino Biologics)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Convidecia"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Convidecia"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000005",
"display" : "COVID-19-Impfstoff EpiVacCorona (Vektor-Institut)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff EpiVacCorona (Vektor-Institut)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:EpiVacCorona"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "EpiVacCorona"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000006",
"display" : "COVID-19-Impfstoff BBIBP-CorV (Sinopharm)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff BBIBP-CorV (Sinopharm)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:BBIBP-CorV"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "BBIBP-CorV"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000007",
"display" : "COVID-19-Impfstoff Inactivated-SARS-CoV-2-Vero-Cell",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Inactivated-SARS-CoV-2-Vero-Cell"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Inactivated-SARS-CoV-2-Vero-Cell"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_PartName",
"valueString" : "Vero-Cell"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "status",
"valueCode" : "retired"
}
]
},
{
"code" : "AUSL_000008",
"display" : "COVID-19-Impfstoff CoronaVac (Sinovac Biotech)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff CoronaVac (Sinovac Biotech)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:CoronaVac"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "CoronaVac"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000009",
"display" : "COVID-19-Impfstoff Covaxin (Bharat Biotech)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Covaxin (Bharat Biotech)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Covaxin"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_PartName",
"valueString" : "Covaxin"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000010",
"display" : "COVID-19-Impfstoff Covishield (Serum Institute of India)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Covishield (Serum Institute of India)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Covishield"
},
{
"code" : "ELGA_PartName",
"valueString" : "Covishield"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000011",
"display" : "COVID-19-Impfstoff Covid-19 (recombinant) (Fiocruz)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Covid-19 (recombinant) (Fiocruz)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Covid-19-recombinant"
},
{
"code" : "ELGA_PartName",
"valueString" : "Covid-19-recombinant"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000012",
"display" : "COVID-19-Impfstoff R-COVI (R-Pharm CJSC)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff R-COVI (R-Pharm CJSC)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:R-COVI"
},
{
"code" : "ELGA_PartName",
"valueString" : "R-COVI"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000013",
"display" : "COVID-19-Impfstoff CoviVac (Chumakov-Federal-Scientific-Center)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff CoviVac (Chumakov-Federal-Scientific-Center)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:CoviVac"
},
{
"code" : "ELGA_PartName",
"valueString" : "CoviVac"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000014",
"display" : "COVID-19-Impfstoff Sputnik-Light (Gamaleya)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Sputnik-Light (Gamaleya)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Sputnik-Light"
},
{
"code" : "ELGA_PartName",
"valueString" : "Sputnik-Light"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000015",
"display" : "COVID-19-Impfstoff Hayat-Vax (Gulf Pharmaceutical Industries)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Hayat-Vax (Gulf Pharmaceutical Industries)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Hayat-Vax"
},
{
"code" : "ELGA_PartName",
"valueString" : "Hayat-Vax"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000016",
"display" : "COVID-19-Impfstoff Abdala (Center for Genetic Engineering and Biotechnology)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Abdala (Center for Genetic Engineering and Biotechnology)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Abdala"
},
{
"code" : "ELGA_PartName",
"valueString" : "Abdala"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000017",
"display" : "COVID-19-Impfstoff WIBP-CorV (Sinopharm - Wuhan Institute of Biological Products)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff WIBP-CorV (Sinopharm - Wuhan Institute of Biological Products)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:WIBP-CorV"
},
{
"code" : "ELGA_PartName",
"valueString" : "WIBP-CorV"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000018",
"display" : "COVID-19-Impfstoff MVC COVID-19 vaccine (Medigen Vaccine Biologics Corporation)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff MVC COVID-19 vaccine (Medigen Vaccine Biologics Corporation)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:MVC-COV1901"
},
{
"code" : "ELGA_PartName",
"valueString" : "MVC-COV1901"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000019",
"display" : "COVID-19-Impfstoff Covovax (Serum Institute Of India Private Limited)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Covovax (Serum Institute Of India Private Limited)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Covovax"
},
{
"code" : "ELGA_PartName",
"valueString" : "Covovax"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000020",
"display" : "COVID-19-Impfstoff Vidprevtyn (Sanofi Pasteur)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Vidprevtyn (Sanofi Pasteur)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Vidprevtyn"
},
{
"code" : "ELGA_PartName",
"valueString" : "Vidprevtyn"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "status",
"valueCode" : "retired"
}
]
},
{
"code" : "AUSL_000021",
"display" : "COVID-19-Impfstoff VLA2001 (Valneva France)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff VLA2001 (Valneva France)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:VLA2001"
},
{
"code" : "ELGA_PartName",
"valueString" : "VLA2001"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
},
{
"code" : "status",
"valueCode" : "retired"
}
]
},
{
"code" : "AUSL_000022",
"display" : "COVID-19-Impfstoff EpiVacCorona-N (Vector Institute)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff EpiVacCorona-N (Vector Institute)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:EpiVacCorona-N"
},
{
"code" : "ELGA_PartName",
"valueString" : "EpiVacCorona-N"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000023",
"display" : "COVID-19-Impfstoff Sputnik-M (Gamaleya Research Institute)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Sputnik-M (Gamaleya Research Institute)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Sputnik-M"
},
{
"code" : "ELGA_PartName",
"valueString" : "Sputnik-M"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000024",
"display" : "COVID-19-Impfstoff Vacina adsorvida covid-19 (inativada) (Instituto Butantan)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Vacina adsorvida covid-19 (inativada) (Instituto Butantan)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Covid-19-adsorvida-inativada"
},
{
"code" : "ELGA_PartName",
"valueString" : "Covid-19-adsorvida-inativada"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000025",
"display" : "COVID-19-Impfstoff NVSI-06-08 (National Vaccine and Serum Institute, China)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff NVSI-06-08 (National Vaccine and Serum Institute, China)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:NVSI-06-08"
},
{
"code" : "ELGA_PartName",
"valueString" : "NVSI-06-08"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000026",
"display" : "COVID-19-Impfstoff YS-SC2-010 (Yisheng Biopharma)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff YS-SC2-010 (Yisheng Biopharma)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:YS-SC2-010"
},
{
"code" : "ELGA_PartName",
"valueString" : "YS-SC2-010"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000027",
"display" : "COVID-19-Impfstoff SCTV01C (Sinocelltech Ltd.)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff SCTV01C (Sinocelltech Ltd.)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:SCTV01C"
},
{
"code" : "ELGA_PartName",
"valueString" : "SCTV01C"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000028",
"display" : "COVID-19-Impfstoff Covifenz (Medicago Inc.)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Covifenz (Medicago Inc.)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Covifenz"
},
{
"code" : "ELGA_PartName",
"valueString" : "Covifenz"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000029",
"display" : "COVID-19-Impfstoff AZD2816 (AstraZeneca AB)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff AZD2816 (AstraZeneca AB)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:AZD2816"
},
{
"code" : "ELGA_PartName",
"valueString" : "AZD2816"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000030",
"display" : "COVID-19-Impfstoff Soberana 02 (Finlay-Institute)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Soberana 02 (Finlay-Institute)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Soberana-02"
},
{
"code" : "ELGA_PartName",
"valueString" : "Soberana-02"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AUSL_000031",
"display" : "COVID-19-Impfstoff Soberana Plus (Finlay-Institute)",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "COVID-19-Impfstoff Soberana Plus (Finlay-Institute)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:Soberana-Plus"
},
{
"code" : "ELGA_PartName",
"valueString" : "Soberana-Plus"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:840534001"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "COVID-19 Impfstoff"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX03"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Covid-19 Vakzine"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073629"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "Art der Anwendung nicht spezifizierbar"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:13759403"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "CORONAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:900000000037"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "nicht definiert"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AWEG_000001",
"display" : "FLUZONE/EFLUELDA 10St",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Fluzone High-Dose Quadrivalent"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:NDC49281-405-65"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "10"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Pasteur"
},
{
"code" : "ELGA_PartName",
"valueString" : "Efluelda"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074047"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AWEG_000002",
"display" : "QUADRIVALENT INFLUENZA SANOFI 1ST",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Quadrivalent Influenza Vaccine suspension for injection in prefilled syringe (Sanofi)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:PL46602/0017"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Sanofi Pasteur Europe"
},
{
"code" : "ELGA_PartName",
"valueString" : "Efluelda"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074047"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionsl�sung in einer Fertigspritze"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AWEG_000003",
"display" : "INFLUSPLIT TETRA 1ST",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "Influsplit Tetra 2020/2021 Injektionssuspension in Fertigspritze"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:PEI.H.11629.01.1"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "false"
},
{
"code" : "GroesseGewicht",
"valueString" : "1"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073544"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Fertigspritze"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836377006"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Influenza Impfstoff"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "GlaxoSmithKline GmbH & Co. KG"
},
{
"code" : "ELGA_PartName",
"valueString" : "Influsplit Tetra"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BB02"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "Influenza, gereinigtes Antigen"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073600"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "intramuskul�re Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:1708839"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "INFLUENZAVIRUS (AUSZUG, PRODUKTE)"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:100000091392"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "IMMUNOSERA FOR HUMAN USE, ANIMAL"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000074063"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension for injection in pre-filled syringe"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AWEG_000004",
"display" : "JYNNEOS 20ST",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "JYNNEOS Suspension for subcutaneous injection"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.3.1.2.14.1:50632-001-02"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "20"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836389008"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Mpox-/Pocken Impfstoff"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_PartName",
"valueString" : "JYNNEOS"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "andere virale Impfstoffe"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:7666876"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "VACCINIAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004720"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "VACCINIA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004720"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "VACCINIA VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:200000010620"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Suspension and solution for suspension for injection"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
},
{
"code" : "AWEG_000005",
"display" : "IMVANEX 20ST",
"property" : [
{
"code" : "Bezeichnung_Arzneispezialitaet_Zulassung",
"valueString" : "IMVANEX Injektionssuspension Pockenimpfstoff (Modifiziertes Vacciniavirus Ankara, lebend)"
},
{
"code" : "ZulassungsNummer",
"valueString" : "1.2.40.0.34.4.17:EU/1/13/855/001"
},
{
"code" : "ELGA_G�ltigkeit",
"valueString" : "true"
},
{
"code" : "ELGA_MedikationPackungsstatusLieferbar",
"valueString" : "true"
},
{
"code" : "GroesseGewicht",
"valueString" : "20"
},
{
"code" : "ELGA_MedikationMengenart_code",
"valueString" : "2.16.840.1.113883.6.8:{Stueck}"
},
{
"code" : "ELGA_MedikationMengenart_text",
"valueString" : "St�ck"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.7:100000072079"
},
{
"code" : "ELGA_MedikationRezeptpflichtStatus_text",
"valueString" : "Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung"
},
{
"code" : "ELGA_Packaging_01_code",
"valueString" : "1.2.40.0.34.5.219:100000073563"
},
{
"code" : "ELGA_Packaging_01_text",
"valueString" : "Durchstechflasche"
},
{
"code" : "ELGA_ImpfungIndikation_01_code",
"valueString" : "2.16.840.1.113883.6.96:836389008"
},
{
"code" : "ELGA_ImpfungIndikation_01_text",
"valueString" : "Mpox-/Pocken Impfstoff"
},
{
"code" : "ELGA_Inhaber",
"valueString" : "Bavarian Nordic A/S"
},
{
"code" : "ELGA_PartName",
"valueString" : "IMVANEX"
},
{
"code" : "ELGA_whoATC_01_code",
"valueString" : "2.16.840.1.113883.6.73:J07BX"
},
{
"code" : "ELGA_whoATC_01_text",
"valueString" : "andere virale Impfstoffe"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.4:100000073633"
},
{
"code" : "ELGA_MedikationArtAnwendung_01_text",
"valueString" : "subkutane Anwendung"
},
{
"code" : "ELGA_Substanz_01_code",
"valueString" : "1.2.40.0.34.5.156:7666876"
},
{
"code" : "ELGA_Substanz_01_text",
"valueString" : "VACCINIAVIRUS"
},
{
"code" : "ELGA_ActiveIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004720"
},
{
"code" : "ELGA_ActiveIngredient_01_text",
"valueString" : "VACCINIA VIRUS"
},
{
"code" : "ELGA_Ingredient_role_01_text",
"valueString" : "active"
},
{
"code" : "ELGA_ReferenceIngredient_01_code",
"valueString" : "1.2.40.0.34.5.221:900000004720"
},
{
"code" : "ELGA_ReferenceIngredient_01_text",
"valueString" : "VACCINIA VIRUS"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_code",
"valueString" : "1.2.40.0.10.1.4.3.4.3.5:100000073864"
},
{
"code" : "ELGA_MedikationDarreichungsform_01_text",
"valueString" : "Injektionssuspension"
},
{
"code" : "ELGA_MedikationWechselwirkungsRelevant",
"valueString" : "true"
},
{
"code" : "Domaene",
"valueString" : "human"
}
]
}
],
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.